Aitia

About:

Leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs

Website: https://www.aitiabio.com/

Twitter/X: Aitiabio

Top Investors: Alexandria Venture Investments, Alexandria Real Estate Equities, Mitsui & Co, Echo Health Ventures, Amgen Ventures

Description:

Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development. Aitia’s partners include seven of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally.